Novel Health Strategies is celebrating the seventh year of its thought leadership in healthcare, with the recent publication in Nature Biotechnology, called 'What's fueling the biotech engine'.
The strong foundation of thought leadership has enabled the Novel Health Strategies team to develop innovative, effective and efficient solutions for several drug and device manufacturers.
These publications are the best examples of our team's strategic thinking, knowledge, quality and depth of our work.
WHAT'S FUELING THE BIOTECH ENGINE SERIES
This article is an annual and recurring series published in Nature Biotechnology since 2006. The article provides strategy overview on clinical, HEOR, sales, pricing, reimbursement, regulatory trends and competitive dynamics for more than a hundred specialty biologics.
This study is the result of more than seven years of cumulative research, analyses and interviews with various stakeholders.
This series has been cited and quoted by more than four hundred peer-reviewed publications and agencies (FDA, EMA and others)
Top Strategy Mishaps of 2011-2012
NOVEL's team analyzed all product launches of 2011 and 2012 and developed a list of top strategy mishaps. This report also presents the lessons learned and implications for future products.More
HEOR, Pricing and Marketing Strategy for Cancer Therapies
Oncology is the highest selling indication for pharmaceutical products. In a recent event NOVEL's team discussed the 10-years trends in oncology drug development.More
Developing GVD for Pricing & Market Access Success
GVD is the single and central strategy resource for pricing and reimbursement of medical products. NOVEL's team recently hosted a webinar on strategies for developing GVDs.More
Economic Models for HTAs, Payers and Providers
Economic models are becoming important tools for demonstrating economic value of new products. In our recent event we presented fundamentals of developing models, interactive design and easy-to-update features.More